Retail Hiring Surges in April Yet Consumer Caution Signals Emerge Roth Capital Raises Target Price Target but Warns Q1 May Have Been a Goldilocks Quarter SpaceX Successfully Launches Starship Rocket on Second Attempt Plus500 Reports 11 Revenue Growth Affirms FullYear Market Expectations Social Security Claiming Strategies Weighing Early Benefits vs Survivors Benefit for a 62YearOld Dell Technologies Stock Reaches New 52Week High Amid Analyst Optimism CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue Home Federal Bancorp Inc of Louisiana HFBL Q3 2025 Earnings Profitability Holds Steady Amid Quiet Market Response Huize Holding HUIZ Q1 2025 Earnings EPS Misses Estimates by a Wide Margin as Stock Declines Slightly Accendra Health Inc ACH Q1 2026 Earnings EPS Beats Estimates by 609 as Loss Narrows to 004 Per Share OppFi Inc Q1 2026 Earnings EPS Surpasses Estimates Amidst Solid Operational Performance Strategic Education Inc STRA Q1 2026 Earnings EPS Misses Expectations as Revenue Details Remain Undisclosed Clean Harbors CLH Holds Steady Near 287 Amid Narrow Trading Range Brookfield Property Partners 5750 BPYPN Holds Steady Near Key Resistance Level Eaton Vance California Municipal Income Trust CEV Holds Steady Near Midpoint of Range Spire Inc SR Edges Higher as Stock Holds Above Key Support Levels Clorox CLX Holds Steady Near 95 as Traders Eye Key Support and Resistance Levels Ameren AEE Holds Steady Near 110 as Utility Sector Navigates Mixed Signals Encompass Health EHC Consolidates Near Key Level After Modest Decline Vine Hill Capital Investment Corp II VHCP Stays Near Trust Value as SPAC Market Waits for Catalyst Revolution Medicines Inc RVMD Slips Slightly Amid Sector Rotation Key Support Levels Tested CNS Pharmaceuticals CNSP Surges Over 7 as Biotech Momentum Builds LB Pharmaceuticals Inc LBRX Breaks Higher as Volume Picks Up Key Resistance Ahead Disneys Star Wars The Mandalorian and Grogu Opens with Lowest Thursday Previews in Franchise History EDUC Q1 2026 Earnings Narrowing Loss Highlights Ongoing Restructuring Cabaletta Bio Holds Steady CABA Stock Rises Slightly Amid Biotech Volatility